Obesity Human Soluble Prorenin Receptor Expressed in Adipose Tissue Improves Insulin Sensitivity and Endothelial Function in Obese Female Mice
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
ABSTRACT Soluble prorenin receptor (sPRR) is a component of the renin-angiotensin system (RAS) identified as a plasma biomarker for human metabolic disease. However, what tissue source of sPRR is implicated in the modulation of metabolic function remains unclear. This study investigated the contribution of human sPRR (HsPRR) produced in the adipose tissue (Adi) on the metabolic and cardiovascular function of lean and obese male and female mice. Adi-HsPRR mice, generated by crossing human sPRR-Myc-tag and Adiponectin/Cre mice, were fed a low-fat or high-fat diet (10% and 60% kCal from fat, respectively) for 20 weeks. Obese Adi-HsPRR mice showed elevated sPRR levels in adipose tissue without affecting adipocyte size or fat depot weight. Despite plasma sPRR being similar between obese Adi-HsPRR and control female mice, a positive correlation between plasma sPRR and adiposity was present only in controls. Obese Adi-HsPRR male mice showed elevated plasma sPRR compared with controls, but no correlation with adiposity was found in either group. Nevertheless, Adi-HsPRR expression improved insulin sensitivity and endothelial function, reduced adipogenic genes mRNA abundance (PPARg, SEBP1C and CD36), and increased plasma Angiotensin 1-7 levels only in obese HsPPR female mice. Taken together, elevated HsPRR in adipose tissue improved metabolic and vascular function in obese female mice despite normal circulating levels of sPRR, whereas increased local and circulating levels of HsPRR did not influence metabolic and cardiovascular function in obese male mice. Our data suggest that increased plasma sPRR associated with metabolic disease could be produced by other tissues rather than adipocytes.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (45)
- doi:10.1016/j.pcad.2013.09.003 via crossref
- doi:10.1161/hyp.0000000000000202 via crossref
- doi:10.21037/gs.2019.12.03 via crossref
- doi:10.3892/etm.2016.3667 via crossref
- doi:10.1161/circresaha.120.316101 via crossref
- doi:10.2174/1573402118666220216104816 via crossref
- doi:10.1681/asn.2009030300 via crossref
- doi:10.3892/ijmm.18.3.483 via crossref
- doi:10.1172/jci200214276 via crossref
- doi:10.1291/hypres.30.1139 via crossref
- doi:10.1074/jbc.273.18.10939 via crossref
- doi:10.1126/science.1179802 via crossref
- doi:10.1152/ajpregu.00439.2005 via crossref
- doi:10.1016/j.molmet.2016.08.009 via crossref
- doi:10.1161/hypertensionaha.115.06954 via crossref
- doi:10.1074/jbc.m207776200 via crossref
- doi:10.1172/jci.insight.128061 via crossref
- doi:10.1155/2013/493828 via crossref
- doi:10.1089/met.2017.0153 via crossref
- doi:10.1186/s13293-021-00374-3 via crossref
- doi:10.1096/fasebj.2021.35.s1.03254 via crossref
- doi:10.1161/hypertensionaha.119.12906 via crossref
- doi:10.1152/ajpheart.00638.2022 via crossref
- doi:10.1042/cs20201047 via crossref
- doi:10.1371/journal.pone.0100449 via crossref
- doi:10.1152/ajpendo.90617.2008 via crossref
- doi:10.1152/ajpendo.00645.2007 via crossref
- doi:10.1161/hypertensionaha.122.20262 via crossref
- doi:10.1152/ajprenal.00375.2023 via crossref
- doi:10.1007/s40262-013-0072-7 via crossref
- doi:10.1159/000531076 via crossref
- doi:10.1210/jc.2012-4139 via crossref
- doi:10.14814/phy2.13410 via crossref
- doi:10.1007/s00424-012-1120-0 via crossref
- doi:10.1038/s41440-021-00671-9 via crossref
- doi:10.1016/j.peptides.2013.10.022 via crossref
- doi:10.1016/j.peptides.2014.12.012 via crossref
- doi:10.1016/j.atherosclerosis.2017.02.012 via crossref
- doi:10.1016/j.dsx.2019.04.042 via crossref
- doi:10.1212/01.wnl.0000275236.51129.d2 via crossref
- doi:10.1194/jlr.m031591 via crossref
- doi:10.1101/gad.12.20.3182 via crossref
- doi:10.1038/oby.2004.5 via crossref
- doi:10.1101/cshperspect.a009191 via crossref
- doi:10.1093/humrep/dep122 via crossref
Source provenance
- crossref
- last seen: 2026-05-30T01:00:13.054162+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0